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ELECTRONIC LETTER
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Boomerang dysplasia (BD) is a perinatal lethal osteochon-
drodysplasia, characterised by absence or underossification
of the limb bones and vertebrae. The BD phenotype is similar
to a group of disorders including atelosteogenesis I,
atelosteogenesis III, and dominantly inherited Larsen syn-
drome that we have recently shown to be associated with
mutations in FLNB, the gene encoding the actin binding
cytoskeletal protein, filamin B. We report the identification of
mutations in FLNB in two unrelated individuals with
boomerang dysplasia. The resultant substitutions, L171R
and S235P, lie within the calponin homology 2 region of the
actin binding domain of filamin B and occur at sites that are
evolutionarily well conserved. These findings expand the
phenotypic spectrum resulting from mutations in FLNB and
underline the central role this protein plays during skeleto-
genesis in humans.
B
oomerang dysplasia (OMIM #112310) is a lethal
skeletal dysplasia characterised by disorganised skeletal
ossification.1 Characteristic radiological findings include
irregular ossification of the limb bones and vertebrae,
underdevelopment of the acetabulum, and hypoplastic,
boomerang shaped femora from which the disorder derives
its name.1 At least eight cases have been described in the
literature to date.1–8 A similar lethal skeletal dysplasia,
Piepkorn dysplasia,9 has been proposed to be allelic to
boomerang dysplasia.2 7 Cartilage histology demonstrates
both disorganised cartilage anlagen of the developing long
bone and frequent multinucleated chondrocytes in the
reserve zone of the growth plate.1 Other developmental
abnormalities beyond the skeleton have been described,
including omphalocele and encephalocele.
Similarities in the radiographic and histological findings of
boomerang dysplasia and atelosteogenesis I (AOI; OMIM
#108720) and III (AOIII; OMIM #108721) have suggested
allelism for these disorders.2 10 In all three entities, radio-
graphic findings include deficient and irregular ossification of
bones and vertebral bodies with distal humeral hypoplasia
and joint dislocations in addition to craniofacial abnormal-
ities.11 Additionally, multinucleated chondrocytes have been
observed in both AOI and boomerang dysplasia. Boomerang
dysplasia is distinguished from AO on the basis of a more
severe defect in mineralisation, with complete absence of
ossification in some limb elements and vertebral segments.3
A preponderance of males among reported cases of boomer-
ang dysplasia7 and some phenotypic similarities to the
otopalatodigital syndrome spectrum disorders caused by
mutations in the FLNA gene12 13 suggested an X linked
aetiology to some authors.7
Recently we described the association of mutations in the
gene encoding the 280 kDa cytoskeletal protein filamin B
with several disorders characterised by skeletal defects and
joint dislocations.14 Filamin B is a modular protein. An actin
binding domain composed of two calponin homology
domains (CH1 and CH2) is located at the amino terminus,
followed by a rod domain composed of 24 structurally
homologous repeats and terminating in a carboxyterminal
dimerisation domain.15 The actin binding domain in filamin B
is similar to those found in other cytoskeletal proteins, such
as b-spectrin, dystrophin, and a-actinin-4.
Four distinct conditions have been attributed to mutations
in FLNB: AOI, AOIII, recessively inherited spondylcarpotarsal
syndrome (OMIM #272460), and a dominant form of Larsen
syndrome (OMIM #150250). Individuals with AOI, AOIII,
and dominantly inherited Larsen syndrome were found to be
heterozygous for missense mutations in FLNB.14 The majority
Figure 1 Radiograph of case 1. The calvarium, spine, and pubis are
underossified with a thoracic scoliosis evident. There is severe
micromelia with unossified humeri, absent femora, and severely bowed
and shortened radii, ulnae, and tibiae. No ossification is seen in the
hands or feet.
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of the mutations leading to AOI or AOIII lead to substitutions
localised to the CH2 domain of the actin binding domain of
filamin B. The sole exception is the mutation 2251GRC,
located in exon 15, which is predicted to lead to the
substitution G751R in repeat 6, found in an individual with
AOIII.14 During the work that identified the group of
disorders resulting from mutations in FLNB, one individual
with boomerang dysplasia was assessed for mutations by
direct sequencing, but no mutation was identified.14
Given the radiographic, phenotypic, and histological
evidence suggesting that boomerang dysplasia is related to
disorders caused by mutations in genes encoding filamins,
we examined two individuals with boomerang dysplasia for
mutations in FLNA and FLNB using denaturating high
performance liquid chromatography (DHPLC) analysis as
the screening technique.
Individual 1 was the case previously examined by direct
sequencing. This male fetus was the first child of non-
consanguineous, healthy parents. Second trimester ultra-
sound scanning revealed thoracic hypoplasia and marked
shortening of all limbs with irregular ossification of multiple
skeletal elements. The fetus was delivered at 22 weeks’
gestation. Post-mortem analysis demonstrated marked thor-
acic hypoplasia, short limbs, and the characteristic facial
dysmorphism associated with boomerang dysplasia. There
was no encephalocoele or omphalocoele present. The radio-
graphic findings were typical for boomerang dysplasia (fig 1).
Individual 2 was a fetus of 17 weeks’ gestation, previously
reported in detail by Wessels et al.8 This fetus demonstrated
severe micromelia with two of the three long tubular bones
missing in all four limbs. On radiographic examination, the
remaining radii were boomerang shaped, the tibiae were
segment-like, the spine was poorly ossified, and the thorax
was hypoplastic. Histologically, the cartilage matrix was
hypocellular with multinucleated giant chondrocytes present.
The coding regions and intron–exon splice junctions of
both FLNA and FLNB were amplified from genomic DNA
obtained from both cases using intronic primers described
previously13 14 (reaction conditions and primer sequences are
available on request). For analysis of FLNA, amplicon
products were visualised by agarose gel electrophoresis and
then mixed with equal amounts of PCR amplified products
from an unrelated healthy male control before heteroduplex
formation. Samples were subjected to DHPLC on a WAVE
DNA fragment analysis system (Transgenomic Inc.)
according to the manufacturer’s instructions. Amplicons
demonstrating anomalous trace forms were re-amplified
and cycle sequenced on an ABI 3100 sequencer. Identified
mutations were confirmed by restriction enzyme digest of
amplified DNA, and parentage was confirmed as declared for
case 1 by the segregation of six unlinked microsatellite
markers. Parental samples were unavailable for case 2. This
study was approved by the Otago ethics committee.
Examination of FLNB (exons 1–46) revealed mutations in
both subjects. In case 1, the individual was shown to be
heterozygous for the mutation 512TRG, which is predicted to
lead to the substitution L171R. This mutation creates a site
for the restriction enzyme HpaII, enabling the demonstration
that it had arisen de novo in this family (fig 2), providing
genetic evidence of pathogenicity. In retrospect, this muta-
tion was present in the original analysis, but it was
overlooked. The second mutation, 703TRC, was found in
exon 4 in case 2, and predicts the substitution S235P (fig 2).
Parental samples were not available, but this mutation was
not present in 100 control chromosomes. Both mutations are
predicted to alter residues within the CH2 region of the actin
binding domain of filamin B. These residues are highly
evolutionarily conserved among vertebrate filamins (fig 3).
The mutations suggest that these amino acids play a critical
role in actin binding domain function. For the 703TRC
mutation, the same substitution has been observed at the
analogous residue in ACTN4, a gene that encodes the
cytoskeletal adapter protein a-actinin-4 (fig 3), in a patient
with focal and segmental glomerulosclerosis.16
Disease associated substitutions within the actin binding
domain of filamin B lead to a diversity of phenotypes.
Previously we have reported substitutions leading to AOI
(n=3), AOIII (n=1), and Larsen syndrome (n=2).14 All of
these phenotypes are associated with defects in skeletogen-
esis and joint formation. The identification of mutations
leading to substitutions within the actin binding domain of
filamin B in two patients with boomerang dysplasia confirms
that this condition is allelic to these disorders reflecting
previous clinical suspicions of relatedness.2 3
A proportion of mutations that cause the otopalatodigital
spectrum of skeletal disorders lies within the analogous CH2
region in FLNA. These mutations also lead to a broad
spectrum of phenotypic severity.13 There is no simple
correlation between the location of these mutations and the
severity of the resultant defects in skeletal ossification. While
otopalatodigital syndrome type 1 manifests more mildly than
otopalatodigital syndrome type 2, these conditions can result
Figure 2 Chromatograms and
restriction endonuclease digestions
demonstrating mutations associated
with boomerang dysplasia. (A) Case 1,
showing heterozygosity for the mutation
512TRG and restriction endonuclease
digestion using HpaII. Analysis of the
parents (lanes 1 and 3) is shown
alongside that of the proband (lane 2).
(B) Case 2, showing heterozygosity for
the mutation 703TRC, and restriction
endonuclease digestion by DrdI.
Analysis of amplified DNA from the
proband (lane 1) and a healthy,
unrelated control (lane 2). Fragment
sizes are indicated in bp.
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from substitutions at residues in close proximity to one
another or even at the same residue.13 17 The observation that
mutations in the actin binding domain of FLNB can also lead
to a wide spectrum of severity recapitulates this pattern. The
substitution predicted by the mutation found in individual 1,
L171R, is in close proximity to the site of a substitution
(A173V), causative for AOI.14 Similarly, the S235P substitu-
tion reported here is within the same protein fold as E227K, a
substitution associated with the less severe, non-lethal
phenotype, Larsen syndrome.14 Despite reports of disease
associated substitutions in residues within the CH2 of the
actin binding domain of dystrophin, a-actinin-4,17 filamin
A,13 and filamin B,14 a functional role for this protein fold has
not been definitively elucidated. As CH2 domains do not
possess any innate actin binding properties in isolation, it has
been postulated that the role of the CH2 in actin binding is, at
best, an indirect one.18
Filamins act primarily to stabilise actin within the cell,
either as parallel bundles or orthogonal gel networks.19 20
Multiple binding partners have been identified for filamin A,
the vast majority associating through filamin repeats 16–24
(reviewed in Stossel et al21). Five binding partners have been
shown to associate with filamin B: actin, FBLP-1,22 presenilin
(PS1 and PS2),23 and GPIba.24 It remains to be seen whether
mutations within the actin binding domains of filamins A
and B exert their pathogenic effect primarily by disturbing
actin binding or through a functional dependency between
actin association and binding interactions with other
proteins.
Multinucleated giant cells are found among chondrocytes
in the growth plate of individuals with boomerang dysplasia.
These appearances could result from defective cell cleavage
during the proliferation of chondrocytes within the epiphy-
seal growth plate. Previously we have demonstrated wide-
spread expression of FLNB within the growth plate and most
notably in the cleavage furrow of dividing chondrocytes.14
The process of altered cell cleavage leading to both the
defective skeletal patterning and mineralisation in the
boomerang dysplasia/atelosteogenesis group of disorders
remains to be elucidated.
The identification of mutations causing boomerang dys-
plasia in FLNB confirms boomerang dysplasia as part of
the chondrodysplasia spectrum including AOI and III, and
non-lethal Larsen syndrome. Phenotypic overlap between
boomerang dysplasia and AO, as reported here and pre-
viously, and the colocalisation of mutations underlying these
diseases in exons encoding the actin binding domain of FLNB
is indicative of a clinicopathological spectrum for these
disorders. This further broadening of the phenotypic spec-
trum associated with mutations in FLNB highlights the
importance of a functional actin cytoskeleton for many
normal morphogenetic processes, including skeletogenesis.
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